MAPK14 and lung carcinoma: Although SIRT1 overexpression reduces p-p38 in cardiomyocytes under ischemia–reperfusion injury [13], other studies suggest SIRT1 stimulates p-p38 in breast and lung cancer cells as well as in stem cells [14-15].